Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
depression184 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00164 | 35203659 | Biomedicines | Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00489 | 35064417 | Qual Life Res | The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States. | 2022 | Details |
| A00516 | 35054924 | Int J Mol Sci | GLP-1a: Going beyond Traditional Use. | 2022 | Details |
| A00719 | 34990473 | PLoS One | Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. | 2022 | Details |
| A00730 | 34986375 | J Affect Disord | Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies. | 2022 | Details |
| A00941 | 34923459 | Wiad Lek | THE EFFECTIVENESS OF COMPLEX THERAPY WITH THE INCLUSION OF THE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. | 2021 | Details |
| A00957 | 34919585 | PLoS One | Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action. | 2021 | Details |
| A01161 | 34848360 | J Ethnopharmacol | Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. | 2021 | Details |
| A01202 | 34829926 | Biomedicines | Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. | 2021 | Details |
| A01299 | 34797530 | Rheumatol Ther | Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. | 2021 | Details |
| A01945 | 34557498 | Front Med (Lausanne) | Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders. | 2021 | Details |
| A02122 | 34498413 | Pediatr Obes | Recent advances in the epidemiology of nonalcoholic fatty liver disease in children. | 2021 | Details |
| A02511 | 34346124 | Cell Prolif | Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non-alcoholic fatty liver disease. | 2021 | Details |
| A02533 | 34338703 | Food Funct | Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial. | 2021 | Details |
| A02706 | 34277666 | Front Med (Lausanne) | Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02725 | 34272900 | Int J Eat Disord | Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A02856 | 34214585 | Eur J Pharmacol | The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02931 | 34192792 | Horm Metab Res | Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome. | 2021 | Details |
| A02939 | 34190396 | J Cell Mol Med | LncRNA MAYA promotes iron overload and hepatocyte senescence through inhibition of YAP in non-alcoholic fatty liver disease. | 2021 | Details |
| A03184 | 34096467 | Bioengineered | The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. | 2021 | Details |
| A03295 | 34057682 | Cell Mol Neurobiol | The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia. | 2021 | Details |
| A03297 | 34055713 | Front Public Health | Etiology Exploration of Non-alcoholic Fatty Liver Disease From Traditional Chinese Medicine Constitution Perspective: A Cross-Sectional Study. | 2021 | Details |
| A03329 | 34043121 | Dig Dis Sci | Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention. | 2021 | Details |
| A03337 | 34037296 | Liver Int | Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study. | 2021 | Details |
| A03379 | 34024536 | Clin Nutr ESPEN | Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial. | 2021 | Details |
| A03541 | 33962617 | Health Qual Life Outcomes | Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey. | 2021 | Details |
| A03863 | 33840662 | J Oleo Sci | Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/apoER2 Pathway. | 2021 | Details |
| A04229 | 33706839 | Epidemiol Psychiatr Sci | Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity. | 2021 | Details |
| A04431 | 33618780 | Br J Nutr | Dietary and metabolic risk of neuropsychiatric disorders: insights from animal models. | 2021 | Details |
| A04582 | 33573415 | Ecol Food Nutr | Food Insecurity and Lipid Profile Abnormalities Are Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Case-Control Study. | 2021 | Details |
| A04586 | 33572544 | J Clin Med | Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition? | 2021 | Details |
| A04632 | 33557031 | Life (Basel) | Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. | 2021 | Details |
| A04695 | 33537324 | Front Med (Lausanne) | Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04932 | 33445096 | J Affect Disord | Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects. | 2020 | Details |
| A05174 | 33346572 | J Pediatr Gastroenterol Nutr | Incidence of Depression and Anxiety in a Cohort of Adolescents With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05760 | 33130334 | Ann Hepatol | Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience. | 2020 | Details |
| A06184 | 32977263 | J Affect Disord | Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation. | 2020 | Details |
| A06286 | 32941676 | J Clin Hypertens (Greenwich) | Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. | 2020 | Details |
| A06337 | 32923833 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression. | 2020 | Details |
| A06499 | 32851764 | Liver Int | Health related quality of life in chronic liver diseases. | 2020 | Details |
| A06533 | 32836224 | Dig Dis | Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. | 2020 | Details |
| A06889 | 32708059 | Biomedicines | Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH. | 2020 | Details |
| A06915 | 32698692 | United European Gastroenterol J | Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. | 2020 | Details |
| A07398 | 32514465 | JGH Open | No association between binge eating disorder and severity of non-alcoholic fatty liver disease in severely obese patients. | 2020 | Details |
| A07760 | 32362329 | Prog Med Chem | P2X7 receptor antagonists for the treatment of systemic inflammatory disorders. | 2020 | Details |
| A07954 | 32300995 | Hepatol Int | Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population. | 2020 | Details |
| A08380 | 32134732 | J Basic Clin Physiol Pharmacol | Silymarin: not just another antioxidant. | 2020 | Details |
| A08470 | 32097572 | Annu Rev Clin Psychol | Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. | 2020 | Details |
| A08551 | 32064187 | Cureus | Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08630 | 32039365 | JHEP Rep | The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study. | 2019 | Details |
| A09774 | 31614690 | Int J Mol Sci | Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. | 2019 | Details |
| A10365 | 31373184 | J Korean Med Sci | Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population. | 2019 | Details |
| A10457 | 31328300 | Aliment Pharmacol Ther | Depression is associated with non-alcoholic fatty liver disease among adults in the United States. | 2019 | Details |
| A11021 | 31080056 | Ann Hepatol | Non-alcoholic fatty liver disease and neurological defects. | 2019 | Details |
| A11066 | 31061050 | BMJ Open | Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort. | 2019 | Details |
| A11449 | 30889997 | Expert Opin Ther Pat | A patent update on cannabinoid receptor 1 antagonists (2015-2018). | 2019 | Details |
| A12875 | 30247335 | Nurs Res | Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A13152 | 30112561 | Sheng Li Xue Bao | [Bioinformatics analysis of genes related to pathogenesis of major depression disorder]. | 2018 | Details |
| A13406 | 29992631 | J Eur Acad Dermatol Venereol | Position statement for the management of comorbidities in psoriasis. | 2018 | Details |
| A13934 | 29682494 | Can J Gastroenterol Hepatol | Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14055 | 29608442 | Eur J Gastroenterol Hepatol | Cognitive assessment of patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A14387 | 29432207 | J Pediatr Endocrinol Metab | Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic. | 2018 | Details |
| A14798 | 29226116 | Can J Gastroenterol Hepatol | Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15466 | 28894050 | Postepy Hig Med Dosw (Online) | Compounds of psoriasis with obesity and overweight. | 2017 | Details |
| A15868 | 28676747 | Front Hum Neurosci | Inflammation: The Common Pathway of Stress-Related Diseases. | 2017 | Details |
| A15906 | 28658094 | Medicine (Baltimore) | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management. | 2017 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A16071 | 28585435 | Zool Res | Creating animal models, why not use the Chinese tree shrew (Tupaia belangeri chinensis)? | 2017 | Details |
| A16156 | 28533742 | Front Mol Neurosci | Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? | 2017 | Details |
| A16331 | 28455679 | Curr Obes Rep | Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. | 2017 | Details |
| A16458 | 28376101 | PLoS One | Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy. | 2017 | Details |
| A16749 | 28211165 | Liver Int | A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. | 2017 | Details |
| A16785 | 28178440 | Rambam Maimonides Med J | Comorbidities in Patients with Psoriatic Arthritis. | 2017 | Details |
| A17010 | 28051263 | Eur Rev Med Pharmacol Sci | Psychological factors associated with NAFLD/NASH: a systematic review. | 2016 | Details |
| A17203 | 27916420 | Biomed Pharmacother | Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress. | 2016 | Details |
| A18313 | 27219496 | Endocr Pract | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. | 2016 | Details |
| A18820 | 26921863 | J Affect Disord | Insulin receptor sensitizer, dicholine succinate, prevents both Toll-like receptor 4 (TLR4) upregulation and affective changes induced by a high-cholesterol diet in mice. | 2016 | Details |
| A19633 | 26447006 | JBI Database System Rev Implement Rep | Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A20495 | 25922141 | Eur J Pediatr | Childhood obesity and its physical and psychological co-morbidities: a systematic review of Australian children and adolescents. | 2015 | Details |
| A20734 | 25771129 | Toxicol Appl Pharmacol | Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats. | 2015 | Details |
| A20823 | 25712260 | Brain Behav Immun | Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet. | 2015 | Details |
| A21035 | 25563215 | Eur J Pediatr | The intestinal microbiota: its role in health and disease. | 2015 | Details |
| A21242 | 25460019 | Clin Gastroenterol Hepatol | Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. | 2014 | Details |
| A21280 | 25433921 | Dig Dis Sci | Fibromyalgia symptoms and cirrhosis. | 2014 | Details |
| A21601 | 25194749 | Toxicology | Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration. | 2014 | Details |
| A22485 | 24521540 | Liver Int | Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models. | 2014 | Details |
| A22857 | 24251706 | J Gastroenterol Hepatol | Diet and exercise in management of obesity and overweight. | 2013 | Details |
| A23123 | 24023483 | World J Gastroenterol | What does irritable bowel syndrome share with non-alcoholic fatty liver disease? | 2013 | Details |
| A23172 | 23974690 | Indian J Dermatol Venereol Leprol | Comorbidities in psoriasis. | 2013 | Details |
| A23477 | 23745129 | Hepat Mon | Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. | 2013 | Details |
| A23691 | 23560860 | Liver Int | Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. | 2013 | Details |
| A23734 | 23522007 | Psychol Med | Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations. | 2013 | Details |
| A24026 | 23295007 | Psychosomatics | Association of chronic liver disease with depression: a population-based study. | 2013 | Details |
| A24412 | 22925921 | J Pediatr Gastroenterol Nutr | Psychosocial outcomes for children with nonalcoholic fatty liver disease over time and compared with obese controls. | 2013 | Details |
| A24734 | 22550199 | JAMA | Diagnosis and treatment of depression in adults with comorbid medical conditions: a 52-year-old man with depression. | 2012 | Details |
| A24812 | 22364603 | Actas Dermosifiliogr | [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. | 2012 | Details |
| A25146 | 22139492 | Nihon Shokakibyo Gakkai Zasshi | [A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene]. | 2011 | Details |
| A25718 | 21510837 | Curr Top Med Chem | A new perspective of cannabinoid 1 receptor antagonists: approaches toward peripheral CB1R blockers without crossing the blood-brain barrier. | 2011 | Details |
| A25849 | 21397104 | Psychosomatics | Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. | 2011 | Details |